中国寄生虫学与寄生虫病杂志

• 论著 • 上一篇    下一篇

细粒棘球绦虫转醛醇酶基因的克隆、表达及其潜在免疫诊断价值的研究

辛奇, 景涛*, 宋晓霞, 高海军, 孙旭东, 吕薇, Nabil Pervaiz, 鲁俊   

  1. 兰州大学基础医学院病原生物学研究所, 兰州 730000
  • 出版日期:2017-08-30 发布日期:2017-09-14

ChinaCloning, expression and potential immunodiagnostic evaluation of Echinococcus granulosus transaldolase

XIN Qi, JING Tao*, SONG Xiao-xia, GAO Hai-jun, SUN Xu-dong, LV Wei, Nabil Pervaiz, LU Jun   

  1. Institute of Pathogen Biology, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000,
  • Online:2017-08-30 Published:2017-09-14

摘要:

目的 对细粒棘球绦虫转醛醇酶(Echinococcus granulosus transaldolase, EgTAL)编码基因进行生物信息学分析、克隆和表达, 并对其作为药物靶标及其潜在的免疫诊断价值进行初步评价。 方法 运用多种软件分析EgTAL的理化性质、保守功能域、同源性和三级结构等。从重组质粒pBluescriptⅡSK Egtal中PCR扩增Egtal基因, 克隆至pET30a, 构建表达载体pET30a-Egtal, 转化大肠埃希菌(Escherichia coli) BL21(DE3), 异丙基-β-D-硫代半乳糖苷(IPTG)诱导表达, 十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)分析表达产物, 抗His标签镍亲和层析柱纯化重组蛋白EgTAL, 与细粒棘球蚴病患者血清进行蛋白质印迹(Western blotting)分析。用20份已确诊的细粒棘球蚴病患者血清和20份健康者血清, ELISA法评价重组蛋白EgTAL的免疫诊断效果。分光光度法检测重组蛋白EgTAL的酶活性。 结果 Egtal基因长981 bp, 编码的蛋白含326个氨基酸, 理论相对分子质量(Mr)为36 332, 等电点为5.11, 含TAL标识序列DATTNPSLI(31~39 aa)及酶活性催化部位, EgTAL与人TAL的同源性为62%。三级结构分子建模显示, EgTAL具有A和B两条完整的蛋白链。成功构建重组质粒pET30a-Egtal。SDS-PAGE和Western blotting分析结果显示, 重组蛋白EgTAL在E. coli BL21(DE3)中获得高效表达, 在Mr 36 332处可见重组蛋白EgTAL条带, 主要以可溶性形式存在, EgTAL可被细粒棘球蚴病患者血清识别。ELISA分析结果显示, 20份细粒棘球蚴病患者血清和20份健康者血清的平均A450值分别为1.189±0.384和0.325±0.078, 其中17份细粒棘球蚴病患者血清检测结果为阳性。酶活性检测结果显示, 纯化后的EgTAL具有高效酶活性, 60 μg EgTAL加入酶促反应体系催化反应30 min后, 体系的吸光度(A340值)由1.684±0.103降至0.139±0.009。 结论 克隆了细粒棘球绦虫Egtal基因, 并在E. coli BL21(DE3)中表达出有酶催化活性和潜在免疫诊断价值的EgTAL重组蛋白。

关键词: 细粒棘球绦虫, 转醛醇酶基因, 克隆表达, 免疫诊断, 药物靶点

Abstract:

Objective To perform bioinformatics analysis of the gene encoding Echinococcus granulosus transaldolase(EgTAL), clone and express this gene, and investigate the role of EgTAL as a drug target for anti-hydatid treatment and the diagnostic value. Methods Multiple softwares were employed to analyze the physical and chemical properties, the conserved domain, phylogenetics, and tertiary structure of EgTAL. Egtal gene was amplified and cloned into vector pET30a. The constructed recombinant plasmid pET30a-Egtal was transformed into E.coli BL21 (DE3) for expression under the induction of IPTG. The expressed product was purified with His60 Ni Superflow affinity chromatography and identified by SDS-PAGE and Western blotting in the presence of serum of patient with cystic echinococcosis. The diagnostic value of EgTAL recombinant protein was assessed by ELISA in sera from 20 patients with cystic echinococcosis and from 20 healthy individuals. The enzyme activity of EgTAL was determined by spectrophotometry. Results The Egtal gene showed a length of 981 bp, encoding a 326-amino-acid protein with a predicted Mr of 36 332 and an isoelectric point (PI) of 5.11. The EgTAL protein contained a TAL-specific sequence DATTNPSLI (31-39 aa) and a key catalytic site. The analysis of phylogenetic tree revealed that the homology between EgTAL and human TAL was 62%. The tertiary structure of EgTAL had two complete protein chains, A and B. The pET30a-Egtal recombinant plasmid was constructed. The results of SDS-PAGE and Western blotting indicated that the recombinant protein EgTAL was highly expressed as a soluble protein in E. coli BL21(DE3) with an Mr of 36 332, and can be recognized by serum from patient with cystic echinococcosis. ELISA indicated that the average A450 value of sera from the cystic echinococcosis patients and healthy people were 1.189±0.0384 and 0.325±0.078, respectively, and 17 out of 20 serum samples from the patients showed positive results.The enzyme activity assay revealed that the purified EgTAL recombinant protein had a significant enzyme activity. At 30 min after addition of 60 μg EgTAL into the enzymatic reaction system, the A340 value dropped to 0.139±0.009 from 1.684±0.103.  Conclusion Egtal gene is cloned and recombinant protein EgTAL is highly expressed in E. coli BL21(DE3). The protein EgTAL shows an enzyme activity and potential immunodiagnostic value.

Key words:  Echinnococcus granulosus, Transaldolase gene, Cloning and expression, Immunodiagnosis, Drug target